Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine‐needle aspiration specimens

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

2006 • 5,595 citations

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

2004 • 1,894 citations

Performance Characteristics of Different Modalities for Diagnosis of Suspected Lung Cancer*

2003 • 553 citations

Phase II Study of Efficacy and Safety of Bevacizumab in Combination With Chemotherapy or Erlotinib Compared With Chemotherapy Alone for Treatment of Recurrent or Refractory Non–Small-Cell Lung Cancer

2007 • 402 citations

FDA Drug Approval Summary: Bevacizumab (Avastin®) Plus Carboplatin and Paclitaxel as First-Line Treatment of Advanced/Metastatic Recurrent Nonsquamous Non-Small Cell Lung Cancer

2007 • 390 citations

Diagnostic Accuracy of CT-Guided Automated Needle Biopsy of Lung Nodules

2000 • 285 citations

Transthoracic needle biopsy of small pulmonary nodules.

1997 • 191 citations

p63 Expression in Lung Carcinoma

2004 • 160 citations

p63 and TTF-1 Immunostaining: A Useful Marker Panel for Distinguishing Small Cell Carcinoma of Lung From Poorly Differentiated Squamous Cell Carcinoma of Lung

2003 • 142 citations

Role of Anti-angiogenesis Agents in Treating NSCLC: Focus on Bevacizumab and VEGFR Tyrosine Kinase Inhibitors

2007 • 129 citations

Bronchogenic carcinoma: radiologic-pathologic correlation.

1994 • 114 citations

Distinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma: an immunohistochemical approach

2004 • 107 citations

TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material

2006 • 104 citations

Utility of WT‐1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions

2007 • 93 citations

Bevacizumab in Non–Small Cell Lung Cancer

2007 • 81 citations

p63 and TTF-1 Immunostaining: A Useful Marker Panel for Distinguishing Small Cell Carcinoma of Lung From Poorly Differentiated Squamous Cell Carcinoma of Lung

2003 • 81 citations

Percutaneous fine needle aspiration biopsy of the lung. A study of 1,015 patients.

1984 • 79 citations

The Changing Radiographic Presentation of Bronchogenic Carcinoma With Reference to Cell Types

1996 • 72 citations

Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors Vandetanib (ZD6474) and AZD2171 in Lung Cancer

2007 • 50 citations

Radiographic Manifestations of Primary Bronchogenic Carcinoma

1990 • 48 citations

On-site evaluation of percutaneous CT-guided fine needle aspiration of pulmonary lesions. A study of 321 cases.

2005 • 43 citations

Transthoracic aspiration cytology of pulmonary lesions.

1986 • 28 citations

The role of immunohistochemistry in distinguishing squamous cell carcinoma from mesothelioma and adenocarcinoma in pleural effusion

2006 • 26 citations

Angiogenesis inhibition in the treatment of lung cancer.

2006 • 13 citations

[Clinical role of CT-guided transthoracic needle biopsy in the diagnosis of solitary pulmonary nodules].

1998 • 7 citations